To create a model for investigating whether the immunomodulatory function of IL-31 affects tumor progression, we generated stable IL-31-expressing PyMT and EMT6 breast carcinoma cell lines (PyMT-IL-31 and EMT6-IL-31, respectively) using lentiviral transduction. This evidence concerns the gene IL31 and neoplasm.